0001567619-23-004942.txt : 20230313
0001567619-23-004942.hdr.sgml : 20230313
20230313170646
ACCESSION NUMBER: 0001567619-23-004942
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230307
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ModernaTX, Inc.
CENTRAL INDEX KEY: 0001962626
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 23728107
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-800-4592
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Carisma Therapeutics Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 2674916422
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: Sesen Bio, Inc.
DATE OF NAME CHANGE: 20180516
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
3
1
doc1.xml
FORM 3
X0206
3
2023-03-07
0
0001485003
Carisma Therapeutics Inc.
CARM
0001962626
ModernaTX, Inc.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
0
1
0
Common Stock
5059338
D
Pursuant to a reverse-merger transaction consummated on March 7, 2023, the Reporting Person became the beneficial owner of 12.57% of the Issuer's total shares outstanding.
Brian Sandstrom, Assistant Secretary
2023-03-13